CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.
AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research ...
Achieved 98% manufacturing batch success rate at BaseCamp across cell therapy, viral vector, and mRNA – Positioned U.S.-based biomanufacturing hub to supply genetic medicine products across North ...
Junevity, a biotechnology company on a mission to extend lifespan and healthspan with cell reprogramming, today announced the publication of a peer-reviewed study in Proceedings of the National ...
Microalgae excel at capturing carbon dioxide and converting it into high-value compounds such as lipids (oils) and terpenoids ...
Zacks Investment Research on MSN

Three genomics stocks worth tracking this year

An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
Zebrafish (Danio Rerio) have emerged as a powerful bioengineering platform for next-generation drug discovery, offering an unparalleled combination of ...
Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, announced that it ...
Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.
Scientists have used CRISPR to give the goldenberry a modern makeover, shrinking the plant by about a third and making it ...